New research indicates that patients who come off blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on lost weight much more quickly than those who stop conventional lifestyle regimens.
Research printed in a leading health publication points out that while obese individuals can lose substantial amounts of their total mass while on the medication, the weight is regained at an average rate of 0.8 kg per month upon discontinuation.
"People using these treatments must be informed of the danger of fast rebound weight gain when the medication concludes," cautioned researcher Dr. Susan Jebb.
Such speed of regain implies a reversion to original mass within about a year and a half.
Weighing Treatments
The research, which reviewed dozens of trials involving thousands of participants, contrasted the results of these new drugs with other pills.
The team point out that individuals who lose weight through lifestyle changes alone usually experience a more gradual creep back—perhaps 100 grams monthly—post-intervention.
Understanding the Fast Rebound
Experts believe the mechanism of the injections is key to understanding the accelerated regain.
These medications imitate a body's own chemical called GLP-1, which helps regulate appetite.
"Sustained high doses of the hormone levels several times higher than the body's typical production might result in the system to generate a reduced amount of its own natural hormone, and may also lessen responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.
"Discontinuation of this GLP-1 'fix' means hunger is no longer kept in check, making excessive eating far more likely."
A Chronic Disease?
The NHS advise the jabs for people with obesity-related health risks, alongside prescribed lifestyle changes.
Many experts contend that, considering the significant potential of weight regain, the treatment might need to be life-long.
This perspective is echoed by drug manufacturers, who say that the findings "underscore the chronic nature of excess weight," similar to managing conditions like diabetes.
User Testimonies
Users who have discontinued the medication describe a powerful return of hunger.
"It felt as if a switch activating and you're instantly ravenous," said one woman.
This difficulty is compounded if individuals have not established sustainable dietary or behavioural modifications during treatment.
Significant Adoption
Figures indicate that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with demand being substantial.
- Adoption is more common among women than men.
- The middle-aged demographic shows the greatest level of interest.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, experts caution that while these medications are potent agents for weight loss, they are not a magic fix and maintained weight loss relies on combined behavioural support.
